I have exited MMM. Doesn't meet my IRR hurdles.
RBL is undervalued. The market treats it like a retailer when it should be priced as a marketplace. It has an incredible moat. There was to much focus on margins in last quarters earnings. The new CEO also sandbagged on guidance then bought 2mil of stock after earnings. RBL is pretty good risk reward at the moment in my opinion. Assymetric with limited downside.
- Forums
- ASX - By Stock
- Ann: Becoming a substantial holder
I have exited MMM. Doesn't meet my IRR hurdles.RBL is...
Featured News
Add CTT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.020(1.37%) |
Mkt cap ! $566.1M |
Open | High | Low | Value | Volume |
$1.49 | $1.53 | $1.46 | $2.406M | 1.610M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2890 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 17231 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 56568 | 1.480 |
10 | 129409 | 1.475 |
4 | 30721 | 1.470 |
2 | 51996 | 1.460 |
1 | 13731 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 17231 | 2 |
1.495 | 12439 | 1 |
1.500 | 2719 | 1 |
1.505 | 6544 | 1 |
1.510 | 1000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CTT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online